|
|
US 7,576,096 B2 |
|
| Muscarinic acetylcholine receptor antagonists |
| Jakob Busch-Petersen, King of Prussia, Pa. (US); Michael R. Palovich, King of Prussia, Pa. (US); Zehong Wan, King of Prussia, Pa. (US); Hongxing Yan, King of Prussia, Pa. (US); and Chongjie Zhu, King of Prussia, Pa. (US) |
| Assigned to Glaxo Group Limited, Greenford, Middlesex (United Kingdom) |
| Filed on Jun. 21, 2007, as Appl. No. 11/766,371. |
| Application 11/766371 is a continuation of application No. 10/575839, granted, now 7,276,521, previously published as PCT/US2004/033638, filed on Oct. 12, 2004. |
| Claims priority of provisional application 60/511009, filed on Oct. 14, 2003. |
| Prior Publication US 2007/0238752 A1, Oct. 11, 2007 |
| This patent is subject to a terminal disclaimer. |
| Int. Cl. C07D 451/02 (2006.01); A01N 43/42 (2006.01)
|